{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:48:15Z","timestamp":1788000495472,"version":"build-2784847793"},"reference-count":24,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,9,30]]},"DOI":"10.1536\/ihj.25-305","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:09:01Z","timestamp":1759183741000},"page":"874-882","source":"Crossref","is-referenced-by-count":2,"title":["Epinephrine and Depletion of Female Sex Hormone Exacerbate the Pathology of Obesity-Induced Cardiac Phenotype"],"prefix":"10.1536","volume":"66","author":[{"given":"Masayuki","family":"Toyoda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tokiwa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genri","family":"Numata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"Isotope Science Center, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare"},{"name":"Department of Frontier Cardiovascular Science, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiki","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shimokawa H, Miura M, Nochioka K, <i>et al<\/i>. Heart failure as a general pandemic in Asia. Eur J Heart Fail 2015; 17: 884-92.","DOI":"10.1002\/ejhf.319"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Owan TE, Hodge DO, Herges RM, <i>et al<\/i>. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-9.","DOI":"10.1056\/NEJMoa052256"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsutsui H, Isobe M, Ito H, <i>et al<\/i>. JCS 2017\/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure. Circ J 2019; 83: 2084-184.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Anker SD, Butler J, Filippatos G, <i>et al<\/i>. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 2021; 385: 1451-61.","DOI":"10.1056\/NEJMoa2107038"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2017; 14: 591-602.","DOI":"10.1038\/nrcardio.2017.65"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Shah SJ, Katz DH, Selvaraj S, <i>et al<\/i>. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 2015; 131: 269-79.","DOI":"10.1161\/CIRCULATIONAHA.114.010637"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Redfield MM, Jacobsen SJ, Borlaug BA, <i>et al<\/i>. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005; 112: 2254-62.","DOI":"10.1161\/CIRCULATIONAHA.105.541078"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chung AK, Das SR, Leonard D, <i>et al<\/i>. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation 2006; 113: 1597-604.","DOI":"10.1161\/CIRCULATIONAHA.105.574400"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ueda K, Fukuma N, Adachi Y, <i>et al<\/i>. Sex Differences and Regulatory Actions of Estrogen in Cardiovascular System. Front Physiol 2021; 12: 738218.","DOI":"10.3389\/fphys.2021.738218"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Solomon SD, McMurray JJV, Anand IS, <i>et al<\/i>. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019; 381: 1609-20.","DOI":"10.1056\/NEJMoa1908655"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. McMurray JJV, Jackson AM, Lam CSP, <i>et al<\/i>. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. Circulation 2020; 141: 338-51.","DOI":"10.1161\/CIRCULATIONAHA.119.044491"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Valero-Mu\u00f1oz M, Backman W, Sam F. Murine Models of Heart Failure with Preserved Ejection Fraction: a &quot;Fishing Expedition&quot; . JACC Basic Transl Sci 2017; 2: 770-89.","DOI":"10.1016\/j.jacbts.2017.07.013"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Schiattarella GG, Altamirano F, Tong D, <i>et al<\/i>. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 2019; 568: 351-6.","DOI":"10.1038\/s41586-019-1100-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tong D, Schiattarella GG, Jiang N, <i>et al<\/i>. Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction. Circulation 2019; 140: 1769-71.","DOI":"10.1161\/CIRCULATIONAHA.119.042267"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pacher P, Nagayama T, Mukhopadhyay P, <i>et al<\/i>. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008; 3: 1422-34.","DOI":"10.1038\/nprot.2008.138"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005; 289: H501-12.","DOI":"10.1152\/ajpheart.00138.2005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013; 62: 263-71.","DOI":"10.1016\/j.jacc.2013.02.092"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen Z, Yuhanna IS, Galcheva-Gargova Z, <i>et al<\/i>. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103: 401-6.","DOI":"10.1172\/JCI5347"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sasaki H, Nagayama T, Blanton RM, <i>et al<\/i>. PDE5 inhibitor efficacy is estrogen dependent in female heart disease. J Clin Invest 2014; 124: 2464-71.","DOI":"10.1172\/JCI70731"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bielecka-Dabrowa A, Gryglewska K, Sakowicz A, <i>et al<\/i>. Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women. J Cardiovasc Dev Dis 2022; 9: 238.","DOI":"10.3390\/jcdd9080238"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Paur H, Wright PT, Sikkel MB, <i>et al<\/i>. High levels of circulating epinephrine trigger apical cardiodepression in a \u03b22-adrenergic receptor\/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 2012; 126: 697-706.","DOI":"10.1161\/CIRCULATIONAHA.112.111591"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Templin C, Ghadri JR, Diekmann J, <i>et al<\/i>. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015; 373: 929-38.","DOI":"10.1056\/NEJMoa1406761"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Borlaug BA, Nishimura RA, Sorajja P, <i>et al<\/i>. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588-95.","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Iorga A, Li J, Sharma S, <i>et al<\/i>. Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy. J Am Heart Assoc 2016; 5: e002482.","DOI":"10.1161\/JAHA.115.002482"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-305\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:54:04Z","timestamp":1759550044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-305\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-305","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"article-number":"25-305"}}